Literature DB >> 17522240

Anal cancer: an overview.

Hope E Uronis1, Johanna C Bendell.   

Abstract

Anal cancer is a rare tumor with an incidence that has been rising over the last 25 years. The disease was once thought to develop as a result of chronic irritation, but it is now known that this is not the case. Multiple risk factors, including human papillomavirus (HPV) infection, anoreceptive intercourse, cigarette smoking, and immunosuppression, have been identified. HIV infection is also associated with anal cancer; there is a higher incidence in HIV-positive patients but the direct relationship between HIV and anal cancer has been difficult to separate from the prevalence of HPV in this population. HIV infection is also associated with anal cancer; there are increasing numbers of HIV-positive patients being diagnosed with the disease. Treatment of anal cancer prior to the 1970s involved abdominoperineal resection, but the standard of care is now concurrent chemoradiation therapy, with surgery reserved for those patients with residual disease. We present a case of anal cancer followed by a general discussion of both risk factors and treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17522240     DOI: 10.1634/theoncologist.12-5-524

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  35 in total

Review 1.  Human Papillomavirus Biology, Pathogenesis, and Potential for Drug Discovery: A Literature Review for HIV Nurse Clinical Scientists.

Authors:  Tara Walhart
Journal:  J Assoc Nurses AIDS Care       Date:  2015-07-08       Impact factor: 1.354

Review 2.  Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up.

Authors:  Jyoti Parikh; Aidan Shaw; Lee A Grant; Alexis M P Schizas; Vivek Datta; Andrew B Williams; Nyree Griffin
Journal:  Eur Radiol       Date:  2010-10-03       Impact factor: 5.315

Review 3.  Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA).

Authors:  Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

Review 4.  Radiotherapy alone versus chemoradiotherapy for stage I anal squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Gaurav Talwar; Ryan Daniel; Tyler McKechnie; Oren Levine; Cagla Eskicioglu
Journal:  Int J Colorectal Dis       Date:  2021-01-24       Impact factor: 2.571

5.  [Acute and chronic anal ulcers].

Authors:  G H Weyandt
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

6.  [Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience].

Authors:  M F Osti; L Agolli; C Scaringi; S Bracci; G Minniti; R Maurizi Enrici
Journal:  Radiol Med       Date:  2012-11-26       Impact factor: 3.469

7.  Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.

Authors:  L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

8.  Quality of life outcomes in patients with anal cancer after combined radiochemotherapy.

Authors:  Grit Welzel; Verena Hägele; Frederik Wenz; Sabine Kathrin Mai
Journal:  Strahlenther Onkol       Date:  2011-02-21       Impact factor: 3.621

9.  Modesty and recognition--a qualitative study of the lived experience of recovery from anal cancer.

Authors:  Julie Midtgaard; Mette Juel Hansen; Birgitte Grandjean
Journal:  Support Care Cancer       Date:  2009-01-27       Impact factor: 3.603

10.  Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men.

Authors:  Jasmeet Chadha Singh; Victoria Kuohung; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.